Shiue-Wei Lai Selected Research

Shiue-Wei Lai Research Topics

Disease

7	Neoplasms (Cancer) 02/2024 - 01/2015
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 04/2015
3	Neoplasm Metastasis (Metastasis) 06/2022 - 10/2018
2	Hemophilia A (Haemophilia) 03/2023 - 03/2023
2	Pancreatic Neoplasms (Pancreatic Cancer) 06/2022 - 10/2018
2	Adenocarcinoma 11/2021 - 01/2020
2	Colonic Neoplasms (Colon Cancer) 05/2021 - 01/2021
2	Anemia 02/2021 - 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2024
1	Hepatocellular Carcinoma (Hepatoma) 10/2023
1	Body Weight (Weight, Body) 03/2023
1	Infections 03/2023
1	Hemorrhage 03/2023
1	Insulin Resistance 01/2023
1	Periodontitis 01/2023
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 10/2021
1	Philadelphia Chromosome 10/2021
1	Plasmacytoma 01/2021
1	von Willebrand Diseases (von Willebrand's Disease) 01/2021
1	Type 1 von Willebrand Disease 01/2021
1	Virus Diseases (Viral Diseases) 01/2019
1	Carcinogenesis 10/2018
1	Fever (Fevers) 04/2015
1	Blast Crisis (Blast Phase) 04/2015
1	Sepsis (Septicemia) 04/2015
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2015
1	Necrotizing Fasciitis 03/2015
1	Cachexia 01/2015
1	Inflammation (Inflammations) 01/2015
1	Exanthema (Rash) 04/2014
1	Adenocarcinoma of Lung 04/2014
1	Hemolytic Anemia 01/2013
1	Glucosephosphate Dehydrogenase Deficiency 01/2013
1	Dementia (Dementias) 01/2013

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2015
2	Tyrosine Kinase InhibitorsIBA 10/2021 - 04/2014
2	Imatinib Mesylate (Gleevec)FDA Link 10/2021 - 04/2015
2	Hemoglobins (Hemoglobin)IBA 02/2021 - 01/2019
2	Caspase 3 (Caspase-3)IBA 01/2020 - 10/2018
2	PD 173074IBA 01/2020 - 10/2018
1	dihydrolipoamideIBA 02/2024
1	Sunitinib (Sutent)FDA Link 02/2024
1	CopperIBA 02/2024
1	Protein Phosphatase 1IBA 10/2023
1	Factor VIII (Coagulation Factor VIII)IBA 03/2023
1	Blood Group Antigens (Blood Groups)IBA 03/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	HDL CholesterolIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	Insulin (Novolin)FDA Link 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Fibrinolysin FDA Link 06/2022
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 06/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 06/2022
1	Messenger RNA (mRNA)IBA 06/2022
1	TegafurIBA 05/2021
1	Fluorouracil (Carac)FDA LinkGeneric 05/2021
1	UracilIBA 05/2021
1	VimentinIBA 01/2021
1	von Willebrand FactorIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2019
1	Lactate Dehydrogenase 5IBA 01/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2018
1	Dasatinib (BMS 354825)FDA Link 04/2015
1	bcr-abl Fusion ProteinsIBA 04/2015
1	Azacitidine (5 Azacytidine)FDA Link 03/2015
1	CytokinesIBA 01/2015
1	C-Reactive ProteinIBA 01/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015
1	AlbuminsIBA 01/2015
1	Interleukin-6 (Interleukin 6)IBA 01/2015
1	Tartrate-Resistant Acid PhosphataseIBA 01/2015
1	ErbB Receptors (EGF Receptor)IBA 04/2014
1	Gefitinib (Iressa)FDA Link 04/2014
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2013

Therapy/Procedure

5	Therapeutics 03/2023 - 04/2015
1	Adjuvant Chemoradiotherapy 11/2021
1	Adjuvant Chemotherapy 05/2021
1	Drug Therapy (Chemotherapy) 04/2015
1	Salvage Therapy 04/2015